Thursday, September 29, 2022

Amniotic Membrane for Dry Eye, Keratitis, Recurrent Erosion, Infectious Keratitis, Chemical Burns, Graft Versus Host Disease (GVHD), Stevens Johnson Disease (SJS), Non healing ulcers, Chronic Eye Pain, Neuropathy

In our recent PodCast Dr. Cremers's Podcast, we discussed the uses of Amniotic Membrane and how it works. 

Amniotic Membrane has been uses for so many conditions for the eye (ie, for Dry Eye, Keratitis, Recurrent Erosion, Infectious Keratitis, Chemical Burns, Graft Versus Host Disease (GVHD), Stevens Johnson Disease (SJS), Non healing ulcers, Chronic Eye Pain, Neuropathy) and for the body (ie, non-healing diabetic ulcers, mouth wound, skin wounds, prevention of wound adhesions after surgery, facial rejuvenation (DREAM Procedure: not sure if this is still done..)


Here are some of the references discussed in the podcast. Save your eyes & please list to the podcast.

SLC

References: 

1. 

Published online 2021 Jan 13. doi: 10.3389/fbioe.2020.606982




References:

1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839407/


Amniotic membrane featuresContributing factorsReferences
Biological properties
• Anti-inflammatory effectTrapping inflammatory cells and driving them to apoptosis through its pro-apoptotic agents; production of anti-inflammatory factors by its epithelial cells; suppression the pro-inflammatory cytokines such as interleukin 1 alpha and 1 beta; production of MMP’s inhibitors; expression of migration inhibitory factor (MIF); expression of anti-inflammatory cytokines such as IL-1 receptor antagonist; secretion of anti-inflammatory factors such as PGE2, TGF-β, HGF, TNF-α, and MIF from mesenchymal and epithelial cells of AM
• Antibacterial and antiviral effectExpression of natural antibacterial molecules such as β-defensins, elafin, and cystatin E; adhesion to wound surface and to act as a barrier against bacterial infiltration
• Low antigenicity and non-immunogenicityLack of human leukocyte antigens A, B, C, and DR antigens, or β2-microglobulin on the surface of AM epithelial cells; absence of vessels, lymph, and nerves, in its structure
• Anti-scarring and anti-adhesive effect in wound healingReduction of proteases activity due to the secretion of tissue inhibitors of metalloproteinases (TIMPs); the decreased activity of fibroblasts through downregulation of TGF-β with AM hyaluronic acid content
• Angiogenesis and anti-angiogenesis properties (surface dependent)Angiogenesis properties: secretion of VEGF, IL-8, angiogenin, interferon-γ, IL-6, bFGF, EGF, and PDGF by AM mesenchymal cells Anti-angiogenesis properties: secretion of IL-1, IL-2 receptor antagonist, IL-10, endostatin, TIMP-1, -2, -3, and -4, thrombospondin, and heparin sulfate proteoglycan by AM epithelial cells
• An anticancer agent with low tumorigenicitySecretion of pro-apoptotic agents; secretion of IL-1, IL-2 receptor antagonist, IL-10, and endostatin which all inhibit tumor growth
• Promotion of epithelializationSecretion of growth factors such as EGF, KGF, and HGF
• Pain reliever
• Support cell adhesion and growthIts hyaluronic acid content and proteins such as fibronectin, laminin, collagens, and proteoglycans act as a ligand for integrin receptors
Mechanical properties (intact AM)
• Direct tensile mechanical propertiesPlacental: Force before rupture: 1.2 ± 0.2 N Strain at break: 19% ± 3% N Peripheral: Force before rupture: 0.68 ± 0.08 N Strain at break: 16% ± 1% N
• Young’s modulus2.29–3.6 MPa
• Tensile strength5.475 ± 0.135 MPa
• Elastic modulus4.048 ± 1.702 MPa

5. https://bjo.bmj.com/content/82/3/235.long

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.